CDC Advisory Panel Urges CDC To Resume Johnson & Johnson Vaccines

CBS4's Debra Alfarone reports on the latest panel meeting to resume the usage of the Johnson & Johnson vaccine.

Video Transcript

- [INAUDIBLE] we turn now to a developing story. A panel has just urged the CDC to restart vaccinations using the Johnson & Johnson vaccine.

- The panel spent all day discussing updated recommendations for the use of the one dose vaccine in the US. The vaccine was put on pause after a small number of patients developed a blood clot. CBS 4's Debra Alfarone is live for us in Silver Spring, Maryland with the information just coming in, Debra.

DEBRA ALFARONE: Eliott and Karli, this just came in. This vote just happened. And we learned that a majority voted to continue with the Johnson & Johnson vaccine.

They say it is OK to go ahead in the United States for people age 18 and over. This despite those several blood clot cases. They say simply the benefits outweigh the risks. Soon a CDC advisory committee could vote on whether to resume the use of the one dose Johnson & Johnson vaccine.

- Janssen fully supports the public health recommendations from regulatory agencies and medical society to create general public awareness.

DEBRA ALFARONE: The pause was initiated last week after six reports of rare and severe blood clots. One case resulted in the death of a 45-year-old Virginia woman. During Friday's meeting, panel experts heard about more possible cases, including one Oregon woman in her 50s who died.

- The vast majority of patients have a headache. More severely affected patients can have seizures.

DEBRA ALFARONE: FDA officials say they'll continue working with the CDC to monitor the vaccine for more cases and update the guidance as more information comes to light. Vaccine eligibility in the US was expanded to all adults 16 and older. And now the CDC recommends pregnant women get Pfizer or Moderna vaccines after publishing a study in the New England Journal of Medicine.

ROCHELLE WALENSKY: No safety concerns were observed for people vaccinated in the third trimester, or safety concerns for their babies.

DEBRA ALFARONE: Administration health officials are also launching a new social media campaign to combat vaccine hesitancy, pairing doctors and scientists with celebrities and professional athletes. And they want to meet people where they are. That means social media, YouTube, and podcasts. We're live here in Silver Spring, Maryland tonight. Debra Alfarone. Back to you.